Immunotech Biopharm Ltd
HKEX:6978.HK
Overview | Financials
Company Name | Immunotech Biopharm Ltd |
Symbol | 6978.HK |
Currency | HKD |
Price | 1.52 |
Market Cap | 782,167,678 |
Dividend Yield | 0% |
52-week-range | 1.5 - 5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Dr. Yu Wang |
Website | https://www.eaal.net |
An error occurred while fetching data.
About Immunotech Biopharm Ltd
Immunotech Biopharm Ltd, a cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People's Republic of China. Its core product is EAL, a multi-target cellular immunotherapy product that is in Phase II clinical trials for the
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD